Truncation of Unsilences Paternal and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse Model

English version České info

Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by maternal deficiency of the imprinted gene UBE3A. Individuals with AS suffer from intellectual disability, speech impairment, and motor dysfunction. Currently there is no cure for the disease. Here, we evaluated the phenotypic effect of activating the silenced paternal allele of Ube3a by depleting its antisense RNA Ube3a-ATS in mice. Premature termination of Ube3a-ATS by poly(A) cassette insertion activates expression of Ube3a from the paternal chromosome, and ameliorates many disease-related symptoms in the AS mouse model, including motor coordination defects, cognitive deficit, and impaired long-term potentiation. Studies on the imprinting mechanism of Ube3a revealed a pattern of biallelic transcription initiation with suppressed elongation of paternal Ube3a, implicating transcriptional collision between sense and antisense polymerases. These studies demonstrate the feasibility and utility of unsilencing the paternal copy of Ube3a via targeting Ube3a-ATS as a treatment for Angelman syndrome.

Vyšlo v časopise: Truncation of Unsilences Paternal and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse Model. PLoS Genet 9(12): e32767. doi:10.1371/journal.pgen.1004039
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004039

Souhrn

Zdroje

1. DagliA, BuitingK, WilliamsCA (2012) Molecular and Clinical Aspects of Angelman Syndrome. Mol Syndromol 2: 100–112.

2. WilliamsCA, DriscollDJ, DagliAI (2010) Clinical and genetic aspects of Angelman syndrome. Genet Med 12: 385–395.

3. MabbAM, JudsonMC, ZylkaMJ, PhilpotBD (2011) Angelman syndrome: insights into genomic imprinting and neurodevelopmental phenotypes. Trends Neurosci 34: 293–303.

4. RabinovitzS, KaufmanY, LudwigG, RazinA, ShemerR (2012) Mechanisms of activation of the paternally expressed genes by the Prader-Willi imprinting center in the Prader-Willi/Angelman syndromes domains. Proc Natl Acad Sci U S A 109: 7403–7408.

5. SmithEY, FuttnerCR, ChamberlainSJ, JohnstoneKA, ResnickJL (2011) Transcription is required to establish maternal imprinting at the Prader-Willi syndrome and Angelman syndrome locus. PLoS Genet 7: e1002422.

6. JayP, RougeulleC, MassacrierA, MonclaA, MatteiMG, et al. (1997) The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat Genet 17: 357–361.

7. GlennCC, PorterKA, JongMT, NichollsRD, DriscollDJ (1993) Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Mol Genet 2: 2001–2005.

8. XinZ, AllisCD, WagstaffJ (2001) Parent-specific complementary patterns of histone H3 lysine 9 and H3 lysine 4 methylation at the Prader-Willi syndrome imprinting center. Am J Hum Genet 69: 1389–1394.

9. LossieAC, WhitneyMM, AmidonD, DongHJ, ChenP, et al. (2001) Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet 38: 834–845.

10. MakedonskiK, AbuhatziraL, KaufmanY, RazinA, ShemerR (2005) MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression. Hum Mol Genet 14: 1049–1058.

11. RougeulleC, CardosoC, FontesM, ColleauxL, LalandeM (1998) An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat Genet 19: 15–16.

12. MengL, PersonRE, BeaudetAL (2012) Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Hum Mol Genet 21: 3001–3012.

13. LandersM, BancescuDL, Le MeurE, RougeulleC, Glatt-DeeleyH, et al. (2004) Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. Nucleic Acids Res 32: 3480–3492.

14. ChamberlainSJ, BrannanCI (2001) The Prader-Willi syndrome imprinting center activates the paternally expressed murine Ube3a antisense transcript but represses paternal Ube3a. Genomics 73: 316–322.

15. JohnstoneKA, DuBoseAJ, FuttnerCR, ElmoreMD, BrannanCI, et al. (2006) A human imprinting centre demonstrates conserved acquisition but diverged maintenance of imprinting in a mouse model for Angelman syndrome imprinting defects. Hum Mol Genet 15: 393–404.

16. WuMY, ChenKS, BresslerJ, HouA, TsaiTF, et al. (2006) Mouse imprinting defect mutations that model Angelman syndrome. Genesis 44: 12–22.

17. JiangYH, ArmstrongD, AlbrechtU, AtkinsCM, NoebelsJL, et al. (1998) Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21: 799–811.

18. DindotSV, AntalffyBA, BhattacharjeeMB, BeaudetAL (2008) The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet 17: 111–118.

19. BresslerJ, TsaiTF, WuMY, TsaiSF, RamirezMA, et al. (2001) The SNRPN promoter is not required for genomic imprinting of the Prader-Willi/Angelman domain in mice. Nat Genet 28: 232–240.

20. TsaiTF, JiangYH, BresslerJ, ArmstrongD, BeaudetAL (1999) Paternal deletion from Snrpn to Ube3a in the mouse causes hypotonia, growth retardation and partial lethality and provides evidence for a gene contributing to Prader-Willi syndrome. Hum Mol Genet 8: 1357–1364.

21. CattanachBM, BarrJA, BeecheyCV, MartinJ, NoebelsJ, et al. (1997) A candidate model for Angelman syndrome in the mouse. Mamm Genome 8: 472–478.

22. HuangHS, BurnsAJ, NonnemanRJ, BakerLK, RiddickNV, et al. (2013) Behavioral deficits in an Angelman syndrome model: effects of genetic background and age. Behav Brain Res 243: 79–90.

23. AllensworthM, SahaA, ReiterLT, HeckDH (2011) Normal social seeking behavior, hypoactivity and reduced exploratory range in a mouse model of Angelman syndrome. BMC Genet 12: 7.

24. WeeberEJ, JiangYH, ElgersmaY, VargaAW, CarrasquilloY, et al. (2003) Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J Neurosci 23: 2634–2644.

25. JiangYH, SahooT, MichaelisRC, BercovichD, BresslerJ, et al. (2004) A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A 131: 1–10.

26. XieW, BarrCL, KimA, YueF, LeeAY, et al. (2012) Base-resolution analyses of sequence and parent-of-origin dependent DNA methylation in the mouse genome. Cell 148: 816–831.

27. JiangYH, PanY, ZhuL, LandaL, YooJ, et al. (2010) Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PLoS One 5: e12278.

28. McBeathA, BainN, FourrierM, ColletB, SnowM (2013) A strand specific real-time RT-PCR method for the targeted detection of the three species (vRNA, cRNA and mRNA) of infectious salmon anaemia virus (ISAV) replicative RNA. J Virol Methods 187: 65–71.

29. NaganoT, MitchellJA, SanzLA, PaulerFM, Ferguson-SmithAC, et al. (2008) The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322: 1717–1720.

30. RedrupL, BrancoMR, PerdeauxER, KruegerC, LewisA, et al. (2009) The long noncoding RNA Kcnq1ot1 organises a lineage-specific nuclear domain for epigenetic gene silencing. Development 136: 525–530.

31. PowellWT, CoulsonRL, GonzalesML, CraryFK, WongSS, et al. (2013) R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. Proc Natl Acad Sci U S A doi: 10.1073/pnas.1305426110

32. HuangHS, AllenJA, MabbAM, KingIF, MiriyalaJ, et al. (2012) Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 481: 185–189.

33. KingIF, YandavaCN, MabbAM, HsiaoJS, HuangHS, et al. (2013) Topoisomerases facilitate transcription of long genes linked to autism. Nature 501: 58–62.

34. FangP, Lev-LehmanE, TsaiTF, MatsuuraT, BentonCS, et al. (1999) The spectrum of mutations in UBE3A causing Angelman syndrome. Hum Mol Genet 8: 129–135.

35. MatsuuraT, SutcliffeJS, FangP, GaljaardRJ, JiangYH, et al. (1997) De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 15: 74–77.

36. Mancini-DinardoD, SteeleSJ, LevorseJM, IngramRS, TilghmanSM (2006) Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes. Genes Dev 20: 1268–1282.

37. NumataK, KohamaC, AbeK, KiyosawaH (2011) Highly parallel SNP genotyping reveals high-resolution landscape of mono-allelic Ube3a expression associated with locus-wide antisense transcription. Nucleic Acids Res 39: 2649–2657.

38. LatosPA, PaulerFM, KoernerMV, SenerginHB, HudsonQJ, et al. (2012) Airn transcriptional overlap, but not its lncRNA products, induces imprinted Igf2r silencing. Science 338: 1469–1472.

39. PandeyRR, MondalT, MohammadF, EnrothS, RedrupL, et al. (2008) Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 32: 232–246.

40. MohammadF, MondalT, KanduriC (2009) Epigenetics of imprinted long noncoding RNAs. Epigenetics 4: 277–286.

41. TerranovaR, YokobayashiS, StadlerMB, OtteAP, van LohuizenM, et al. (2008) Polycomb group proteins Ezh2 and Rnf2 direct genomic contraction and imprinted repression in early mouse embryos. Dev Cell 15: 668–679.

42. PrescottEM, ProudfootNJ (2002) Transcriptional collision between convergent genes in budding yeast. Proc Natl Acad Sci U S A 99: 8796–8801.

43. HobsonDJ, WeiW, SteinmetzLM, SvejstrupJQ (2012) RNA polymerase II collision interrupts convergent transcription. Mol Cell 48: 365–374.

44. CramptonN, BonassWA, KirkhamJ, RivettiC, ThomsonNH (2006) Collision events between RNA polymerases in convergent transcription studied by atomic force microscopy. Nucleic Acids Res 34: 5416–5425.

45. CoreLJ, WaterfallJJ, LisJT (2008) Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322: 1845–1848.

46. ChurchmanLS, WeissmanJS (2011) Nascent transcript sequencing visualizes transcription at nucleotide resolution. Nature 469: 368–373.

47. ReeberSL, SillitoeRV (2011) Patterned expression of a cocaine- and amphetamine-regulated transcript peptide reveals complex circuit topography in the rodent cerebellar cortex. J Comp Neurol 519: 1781–1796.

48. NelsonED, KavalaliET, MonteggiaLM (2008) Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J Neurosci 28: 395–406.

49. ZhuPJ, HuangW, KalikulovD, YooJW, PlaczekAN, et al. (2011) Suppression of PKR promotes network excitability and enhanced cognition by interferon-gamma-mediated disinhibition. Cell 147: 1384–1396.

50. HuangW, ZhuPJ, ZhangS, ZhouH, StoicaL, et al. (2013) mTORC2 controls actin polymerization required for consolidation of long-term memory. Nat Neurosci 16: 441–8.

51. DindotSV, PersonR, StrivensM, GarciaR, BeaudetAL (2009) Epigenetic profiling at mouse imprinted gene clusters reveals novel epigenetic and genetic features at differentially methylated regions. Genome Res 19: 1374–1383.

52. YaylaogluMB, TitmusA, ViselA, Alvarez-BoladoG, ThallerC, et al. (2005) Comprehensive expression atlas of fibroblast growth factors and their receptors generated by a novel robotic in situ hybridization platform. Dev Dyn 234: 371–386.